Clinical Trial Update: A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing irinotecan plus cisplatin (IP) versus etoposide plus cisplatin (EP) after EP/TRT for limited-stage small cell lung cancer has completed.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Haruhiko Fukuda | Conditions: Small-Cell-Lung Cancer | Phase 3 | Status: COMPLETED